Moksha8 Raises $39 Million

Moksha8, a San Francisco-based biotech company focused on developing and commercializing high-value therapeutics for Asia and other growth markets, has raised $39 million in combined Series A and Series B funding, according to regulatory filings. TPG Biotech led the $24 million Series A round, and was joined on the $15 million Series B round by Lit Tele LLC of Brazil.